The asymmetric unit of the title compound, C 17 H 23 NO 2 , consists of two crystallographically independent molecules (A and B). The cyclohexene rings in both molecules adopt an envelope conformation. In the crystal, independent molecules, A and B, are each linked by intermolecular bifurcated (N,O)-HÁ Á ÁO hydrogen bonds, generating R 2 1 (7) ring motifs and forming infinite chains along the b axis.
Related literature
For cyclohex-2-enone derivatives and their biological activity, see: Ghorab et al. (2009 Ghorab et al. ( , 2010 ; Ghorab, Al-Said & El-Hossary (2011); Aghil et al. (1992) ; Li & Strobel (2001) . For the biological activity of phenylpropan-2-ylamino, see: Zhang et al. (2011) . For the synthesis of biologically active heterocyclic compounds, see: Ghorab et al. (2012) ; Ghorab, Ragab et al. (2011) . For hydrogen-bond motifs, see: Bernstein et al. (1995) . For ring conformations, see: Cremer & Pople (1975 Refinement R[F 2 > 2(F 2 )] = 0.052 wR(F 2 ) = 0.150 S = 1.08 3114 reflections 379 parameters 1 restraint H atoms treated by a mixture of independent and constrained refinement Á max = 0.18 e Å À3 Á min = À0.17 e Å À3 Table 1 Hydrogen-bond geometry (Å , ). (6) 2.12 (6) 2.874 (4) 155 (5) O2B-H1OBÁ Á ÁO1B i 0.96 (7) 1.75 (7) 2.701 (4) 170 (6) N1A-H1NAÁ Á ÁO1A ii 0.85 (6) 2.04 (6) 2.853 (4) 160 (5) O2A-H1OAÁ Á ÁO1A ii 0.91 (7) 1.88 (7) 2.724 (4) 155 (6) Symmetry codes: (i) Àx þ 2; y À 1 2 ; Àz; (ii) Àx þ 1; y À 1 2 ; Àz þ 2.
Data collection: APEX2 (Bruker, 2009); cell refinement: SAINT (Bruker, 2009); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008) ; program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009 From literature survey it was found that cyclohex-2-enone derivatives are useful in the synthesis of heterocyclic compounds, especially quinoline derivatives (Ghorab et al., 2009 (Ghorab et al., , 2010 Ghorab, Al-Said & El-Hossary, 2011) . Cyclohex-2-enone derivatives also exhibit a wide range of biological activities such as anticancer (Aghil et al., 1992) and antimicrobial (Li & Strobel, 2001) activities. On the other hand, compounds having the phenylpropan-2-ylamino moiety are also known to possess a wide range of biological and pharmacological activities, especially anticancer activity (Zhang et al., 2011) . In the light of these facts and as a continuation of our efforts towards synthesizing biologically active heterocyclic compounds (Ghorab, Ragab et al., 2011; Ghorab et al., 2012) , we prepared a novel cyclohex-2-enone carrying a biologically active phenylpropan-2-ylamino moiety to evaluate its anticancer activity.
The asymmetric unit of the title compound consists of two crystallographically independent molecules (A and B) as shown in Fig. 1 . In both molecules, the cyclohexene rings adopt an envelope conformation with puckering parameters In the crystal (Fig. 2) , molecules are linked by intermolecular bifurcated N1A-H1NA···O1A, N1B-H1NB···O1B, O2A-H1OA···O1A and O2B-H1OB···O1B hydrogen bonds (Table 1) , generating R 2 1 (7) ring motifs (Bernstein et al., 1995) and forming infinite chains along the b axis.
Experimental
A mixture of 5,5-dimethylcyclohexane-1,3-dione (1.4 g, 0.01 mole) and 2-amino-1-phenylpropan-1-ol (1.51 g, 0.01 mole) in dry dimethylformamide (10 ml) containing triethylamine (3 drops) as catalyst was refluxed for 8 h. The obtained solid was recrystallized from ethanol to give the title compound. Single crystals which are suitable for an X-ray structural analysis were obtained by slow evaporation from ethanol at room temperature.
Refinement
Atoms H1NA, H1NB, H1OA and H1OB were located from difference fourier map and refined using a riding model with U iso (H) = 1.5U eq (N or O), [N-H = 0.82 (6) and 0.85 (6) Å; O-H = 0.96 (6) and 0.91 (7) Å]. The remaining H atoms were positioned geometrically (C-H = 0.93, 0.96, 0.97 and 0.98 Å) and refined using a riding model with U iso (H) = 1.2 or 1.5U eq (C). A rotating group model was applied to the methyl groups. An outliner (1 0 0) was omitted. The absolute supplementary materials sup-2 Acta Cryst. (2012). E68, o1436-o1437 configuration cannot be determined because the anomalous dispersions are insufficient although Cu radiation was used.
The crystal is not an inversion twin. In the final refinement, 1395 Friedel pairs were merged.
Computing details
Data collection: APEX2 (Bruker, 2009); cell refinement: SAINT (Bruker, 2009); data reduction: SAINT (Bruker, 2009); program(s) used to solve structure: SHELXTL (Sheldrick, 2008) ; program(s) used to refine structure: SHELXTL (Sheldrick, 2008) ; molecular graphics: SHELXTL (Sheldrick, 2008) ; software used to prepare material for publication:
SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2009 ).
Figure 1
The molecular structure of the title compound with atom labels with 30% probability displacement ellipsoids.
Figure 2
A part of crystal packing of the title compound. The dashed lines represent the hydrogen bonds. Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > σ(F 2 ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
3-[(1-Hydroxy-1-phenylpropan-2-yl)amino]-5,5-dimethylcyclohex-2-enone
R int = 0.051 θ max = 70.0°, θ min = 3.6°h = −12→12 k = −14→13 l = −15→14
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 )
x y z U iso */U eq N1B 0.9656 (3) 0.7034 (2) 0.0647 (2) 0.0564 (7) (4) 
